Kalwak, Krzysztof http://orcid.org/0000-0003-1174-5799
Mielcarek, Monika
Patrick, Katharine
Styczynski, Jan http://orcid.org/0000-0002-3158-119X
Bader, Peter
Corbacioglu, Selim
Burkhardt, Birgit http://orcid.org/0000-0002-1151-829X
Sykora, Karl Walter
Drabko, Katarzyna http://orcid.org/0000-0002-7094-9129
Gozdzik, Jolanta
Fagioli, Franca http://orcid.org/0000-0002-9257-900X
Greil, Johann
Gruhn, Bernd
Beier, Rita
Locatelli, Franco
Müller, Ingo http://orcid.org/0000-0002-7477-6632
Schlegel, Paul Gerhardt
Sedlacek, Petr
Stachel, Klaus Daniel
Hemmelmann, Claudia
Möller, Ann-Kristin
Baumgart, Joachim
Vora, Ajay
Article History
Received: 23 July 2019
Revised: 4 March 2020
Accepted: 10 March 2020
First Online: 20 March 2020
Compliance with ethical standards
:
: KK has received research funding from medac GmbH, Sanofi, and other travel grants. PB has received research funding and patents and royalties from medac GmbH, research funding from Riemser and Neovii. He also received compensation from Cellgene and Novartis for his consultations. In addition, he received compensation from Novartis for Speakers Bureau. BG received honoraria from Jazz Pharmaceuticals. KP received funding from medac GmbH and other funding for EBMT conference fees and accommodation. Prof. KW S received research funding and travel grants from medac GmbH and Aventis-Behring. SC received honoraria for his consultations from Gentium and Jazz Pharmaceuticals. RB received travel grants from medac GmbH and Neovii and is on Bluebird Bio’s advisory board. FL received funding for EBMT/ASH conference fees and accommodation as well as speakers bureau from medac GmbH. AV is on the advisory board for Pfizer, medac GmbH, Novartis, Amgen, and Jazz Pharmaceuticals and also received other funding from them. CH, AKM, and JB are employees of medac GmbH. JB has licensed an employee’s invention (PCT/EP00/10871) to medac GmbH.